ResearcherUniversidad Autónoma de Nuevo LeónActive in the last 2 years

José Francisco Islas

ORCID-verified (high confidence)As of 14 November 2026

Matched on ORCID iD 0000-0002-0337-9912; OpenAlex author ID A5074637696.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers: 2 (first author 0, last author 1)
Pancreatic cancer trials: 0
Pancreatic cancer grants: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Closest collaborators

The 4 strongest of 4 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Paulina Delgado González · 2 shared papers, 2021–2025
- Paper Polyphenols in Pancreatic Cancer Management: Exploring the Roles and Mechanisms of Resveratrol and Epigallocatechin. DOI 10.32604/or.2025.065222 ↗
- Paper Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy. DOI 10.3390/life11111187 ↗
David A. De la Garza Kalife · 1 shared paper, 2025
- Paper Polyphenols in Pancreatic Cancer Management: Exploring the Roles and Mechanisms of Resveratrol and Epigallocatechin. DOI 10.32604/or.2025.065222 ↗
Jorge A. Roacho-Pérez · 1 shared paper, 2021
- Paper Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy. DOI 10.3390/life11111187 ↗
Christian Chapa González · 1 shared paper, 2021
- Paper Target Nanoparticles against Pancreatic Cancer: Fewer Side Effects in Therapy. DOI 10.3390/life11111187 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.